Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 8Observational 2

Sponsor

Cancer Type

Other 9Genitourinary 4Gynecologic 3Gastrointestinal 3Breast 2

Conditions

Breast Neoplasms 2936Neoplasms 174Lung Neoplasms 149Prostatic Neoplasms 116Ovarian Neoplasms 113Colorectal Neoplasms 106Triple Negative Breast Neoplasms 98Colonic Neoplasms 91Neoplasm Metastasis 74Melanoma 66Carcinoma, Non-Small-Cell Lung 64Pancreatic Neoplasms 63Carcinoma, Intraductal, Noninfiltrating 60Stomach Neoplasms 54Head and Neck Neoplasms 47Breast Cancer Female 45Lymphedema 42Uterine Cervical Neoplasms 40Breast Carcinoma In Situ 35Esophageal Neoplasms 34Cardiotoxicity 34Urinary Bladder Neoplasms 33Motor Activity 33Lymphoma 33Endometrial Neoplasms 33Breast Diseases 33Fatigue 30Rectal Neoplasms 28Breast Neoplasms, Male 28Multiple Myeloma 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Insulin Resistance × Breast × Clear all
NCT06830486 2026-02-05

ABIDE

University of Colorado, Denver

Completed
40 enrolled
Breast

Breast Neoplasms, Insulin Resistance, Motor Activity

NCT00304941 2017-07-02

Insulin Resistance and Breast Cancer

National Institutes of Health Clinical Center (CC)

Completed
25 enrolled
Breast

Breast Neoplasms, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡